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Abstract 
A  RP-HPLC  method  has  been  developed  and  validated  for  the  estimation  of  telmisartan in  
bulk  and  pharmaceutical  dosage  form.  A  RP-HPLC  isocratic  separation  was  achieved  on  C18  column 
(250×4.6 mm i.d., 5µm)  utilizing  a  mobile  phase comprising  of  methanol  and  acetonitrile  in  the  ratio  of  
90: 10(v/v)  and  the  eluents  from  the  column  were  detected  using  a  variable  wavelength  detector  at  
237nm.  The  proposed  method has  permitted  the  quantification  of  telmisartan in  the  linearity  range  of  
20-100µg/ml  and  the  flow  rate  was  maintained  at 1ml/min.  The  column  was  maintained  at  ambient 
temperature  and  the  complete  separation  was  achieved  for telmisartan in  an  overall analytical  run  time  
of  approximately  10 minutes. The retention time of telmisartan was found to be 3.3 minutes.  The  limit  of  
detection  and  limit  of  quantification  were  found  to  be 2.82 and 8.54 μg/ml, respectively.  The  percentage  
recovery  was  found  to  be  in  between 87.3  to  103.18%.  The  method  was  found  to  be  suitable  for  the  
routine  quality control analysis  of telmisartan in  bulk  drug  and  formulation.  The method was validated as 
per ICH guidelines. 
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1. Introduction 
 Telmisartan is an angiotension receptor 
blocker that shows high affinity for the angiotension 
II, type 1 receptors, has a long duration of action, and 
has the longest half-life of an ARB. In addition to 
blocking the Renin Angiotensin System (RAS), 
telmisartan acts as a selective modulator of 
Peroxisome proliferators‟ activated receptor gamma 
(PPAR-γ), a central regulator of insulin and glucose 
metabolism. Telmisartan is chemically described as 
4'‐ [(1, 
4'‐dimethyl‐2'‐propyl[2,6'‐bi‐1H‐benzimidazol]‐1'‐yl) 
methyl]‐[1,1'‐biphenyl]‐2‐carboxylic acid. Its 
empirical formula is C33H30N4O2, As shown in 
Figure.1, its molecular weight is 514.63. Literature 
survey reveals that a few analytical methods like 
HPTLC, HPLC and some spectroscopic methods 
have been reported for the estimation of telmisartan 
alone and in combination with other drugs. The 
objective of this study was to develop the method 
with less economical, precise, simple and sensitive. 
Figure 1: Chemical Structure of Telmisartan 
 
 
 
 
 
 
 
 
 
 
2. Materials and Methods 
2.1 Materials  
Telmisartan was obtained as a gift sample 
from Unichem laboratories Ltd, Raigad. The  
commercially  available  tablet, “TELMA”  20 mg 
(Pfizer Ltd., Mumbai) containing 20 mg of 
telmisartan  was  procured  from  the  local market  
and  used  for  analysis. Acetonitrile,  methanol  and  
water  used  were  of  HPLC  grade and  purchased  
from  Merck  specialties  private  limited,  Mumbai,  
India. All the glassware employed in the study was 
cleaned with hot water, followed by acetone and 
dried in hot air oven whenever required. 
2.2 Instrumentation 
Analysis of samples was performed by using 
JASCO PU 2080 HPLC system, a variable 
wavelength programmable UV/VIS detector with 
precision loop injector (Rhenodyne, 20 µl). The data 
was processed by using BORWIN 6.0 software.  All 
samples were filtered through 0.45 µm membrane, 
Millipore filtration apparatus with vacuum pump. 
2.3 Chromatographic conditions  
The isocratic method was employed with the 
mobile phase consisting of 90 volumes of methanol 
and 10 volumes of acetonitrile. The chromatographic 
column used was a HiQ Sil C-18 Column with 
dimensions of 250×4.6 mm with 5 µm particle size. 
The column was maintained at ambient temperature 
and detection was performed at a wavelength of 237 
nm. Prior to injection of analyte, the column was 
equilibrated for 30-40 minutes with mobile phase. 
The injection volume was 20 µL.  Methanol was used 
as diluent for preparation of solutions. 
2.4 Preparation of mobile phase   
The HPLC grade solvents of methanol and 
acetonitrile were used for the preparation of mobile 
phase in the ratio of 90:10 (v/v). The contents of the 
mobile phase were filtered before use through a 
0.45µm membrane filter, degassed by sonication and 
pumped from the solvent reservoir to the column at a 
flow rate of 1ml/min throughout the analysis. 
2.5 Preparation of standard stock solution 
Standard stock solution was prepared by 
dissolving the 10 mg of telmisartan in 10 ml 
methanol to obtain primary stock solution of 1000 
µg/ml. From the primary stock solution; 5ml of the 
solution was pipette out and diluted up to 10 ml with 
methanol to get final concentration of 500 µg/ml.  
2.6 Analysis of tablet formulation 
Twenty tablets were accurately weighed and 
triturate thoroughly to get fine powder. The powder 
equivalent to 20 mg of telmisartan was weighed and 
transferred into 25ml volumetric flask. The contents 
of the flask were dissolved in the 10 ml of the 
methanol with the aid of ultrasonication for 10 
minutes. The solution was filtered through whatmann 
filter paper no. 41 and volume was made up to 25ml 
with methanol. From the resultant solution, further 
dilutions were prepared with methanol to get final 
concentration of telmisartan. The absorbance‟s were 
measured at selected wavelengths and the 
concentration of the analyte was determined with the 
equation obtained from calibration curve. The  results  
of  assay  of  tablets  are  shown  in  Table  3. 
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2.7 Procedure 
A mixture of methanol and acetonitrile in 
the ratio of 90:10 v/v was prepared. The solvent 
mixture was filtered through a 0.45μm membrane 
filter and sonicated before use. It was pumped 
through the column at a flow rate of 1 ml/min. The 
column was maintained at ambient temperature. The 
column was equilibrated by pumping the mobile 
phase through the column for at least 30 minute prior 
to the injection of the drug solution. The detection of 
the drug was monitored at 237 nm. The run time was 
set at 10 minute. Under these optimized 
chromatographic conditions the retention time 
obtained for the drug was 3.3 minute. A typical 
chromatogram showing the separation of the drug is 
given in Figure 2. 
Figure 2: Typical chromatogram of telmisartan 
 
 
2.7.1 Preparation of calibration graph 
Preparation of Level – I (20, 40, 60,80,100 
µg/ml): 0.4, 0.8, 1.2, 1.6 and 2 ml of stock solution 
has  taken in 10 ml of  volumetric flask diluted up to 
the mark with diluent. 
Procedure:   
Injected each level into the chromatographic 
system and measured the peak area. Plotted a graph 
of peak area versus concentration and calculated 
found to be linear in the concentration range of 20-
100 μg/ml of the drug (Figure 3).  
Figure 3: Calibration curve of telmisartan 
 
 
The relevant data are furnished in Table 2. 
The regression equation of this curve was computed.  
The regression equation was later used to estimate 
the amount of telmisartan in tablet dosage forms.  
2.7.2 Validation of the proposed method   
The  specificity, linearity, precision, 
accuracy, limit of detection, limit of quantification 
and robustness parameters were studied 
systematically to validate the proposed HPLC 
method for the  determination of telmisartan.  
2.7.3 LOD and LOQ 
In this study, LOD and LOQ were based on 
the standard deviation of the response (σ) and the 
slope of the corresponding curve (S) using the 
following equation: 
                  LOD = 3.3 σ/S,   LOQ = 10 σ/S 
 Where, σ is the standard deviation of the response of 
blank 
              S is the slope of calibration curve 
The  LOD and  LOQ  of  telmisartan  were  found  to  
be  2.82 μg/ml  and  8.54 μg/ml  respectively.  
2.7.4 Precision   
Precision  is  the  measure  of  how  close  
the  data  values  to  each  other  for  a  number  of 
measurements  under  the  same  analytical  
conditions.  Precision  of  the  method  was  
determined by  performing  inter day  variation,  
intraday  variation  and  repeatability  studies.  Three  
replicate injections  of  the  specific  standard (3 
different concentrations)  at  various  time  intervals  
on  the same  day  were  injected  into  the  
chromatograph  and  the  value  of  % RSD  was  
found  to  be within  the  limits.  In  inter day  
precision,  same  standard  concentrations  were  
injected  on different  days  and  % RSD  was  also  
found  to  be  within  the  limits  for telmisartan.  In 
repeatability study, six determinations of the fixed 
concentration of telmisartan were analyzed 
separately.  The results of precision data are given in 
Table 4. 
2.7.5 Robustness  
To  determine  the  robustness  of  the  
developed  method,  experimental  conditions  were 
purposely  altered  and  the  resolution  was  
evaluated. The flow rate of the mobile phase was 1 
ml/min.  To  study  the  effect  of  flow  rate  on  
resolution,  it  was  changed  by  0.1  units from  0.9  
to  1.1 ml/min.  The  effect  of  percent  organic  
strength  on  resolution  was  studied  by varying  
composition  of  mobile  phase  by  2  units  from  
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methanol: acetonitrile (88:12 v/v)  to methanol: 
acetonitrile (92:08 v/v). The results are given in 
Table 5. 
2.7.6 Specificity 
Marketed  formulation  were  analyzed  to  
determine  the  specificity  of  the  optimized  method  
in the  presence  of  excipients  and  it  was  observed  
that  single  peak  for telmisartan (Rt 3.3 min)  were 
obtained  under  optimized  conditions  (Figure 4),  
showing  no  interference  from  excipients  and  
impurities. Also  the  peak  area  were  compared  
with  the  standard  and  % purity  calculated  was  
found  to be  within  the  limits. 
Figure 4: Chromatogram of marketed formulation 
 
2.7.7 Accuracy (Recovery studies) 
The  accuracy  of  the  proposed  method  
was  determined  by  calculating  the  recoveries  of  
telmisartan by  the  standard  addition  method.  It  
was  determined  by  preparing  solutions  of different  
concentrations  at  80%,  100%  and  120%  of  
60μg/ml  in  which  the  amount  of marketed  
formulation  was  kept  constant  (30 µg/ml)  and  the  
amount  of  pure  drug  was  varied that  is  10µg/ml,  
30µg/ml  and  50µg/ml  for  80%,  100%  and  120%  
respectively.  The  amount of telmisartan recovered  
was  estimated  by  applying  obtained  values  to  the  
regression  line equation.  The results of % recovery 
are given in Table 6. 
 
3. Results and Discussions 
A  simple  RP-HPLC  method  has  been  
developed  for  determination  of  telmisartan. The 
method was optimized to provide a good separation 
of the component (acceptable theoretical plates)  with  
a sufficient  sensitivity  and  suitable  peak  symmetry  
in  a  short  run.  For  this  purpose,  the analytical  
column,  solvent  selection,  mobile  phase  
composition,  flow  rate,  and  detector wavelength  
were  studied.  The chromatographic separation was 
achieved using an RP C18 column.  Our  experiments  
using  methanol  along  with  acetonitrile (HPLC 
grade)  as  mobile phase  was  eluted  the telmisartan 
in  a  significant  shorter  retention  time  of  3.3 
minutes.  Therefore,  we  selected  methanol  and  
acetonitrile  in  the  ratio  of  90:10 (v/v) as  a  mobile  
phase.  The method  has  many  advantages,  e.g., 
simplicity,  isocratic  conditions,  and  absence  of  
buffers  in the  mobile  phase  that  could  damage  
the  chromatographic  column  and  equipment.  
Under these  conditions,  the  retention  time  of 
telmisartan was  about  3.3 minute,  with  a  good  
peak  shape (peak symmetry).  The optimized 
chromatographic conditions are given in Table 1. 
 
Table 1: Optimized chromatographic conditions 
Parameters Optimized conditions 
Chromatograph HPLC (Jasco with UV detector) 
Column HiQ sil C-18 HS (5 µm; 250 × 4.6 mm) 
Mobile phase Methanol : acetonitrile (90 : 10v/v) 
Flow rate 1 ml/min 
Detection wavelength 237 nm 
Injection volume 20 µl 
 
Table 2: Statistical data for linearity and calibration range 
Parameters Telmisartan 
λmax (nm) 237nm (methanol) 
Linearity range 20-100µg/ml 
Correlation coefficient (r2) 0.993 
Regression equation (Y = mx + c) y = 18117x + 26866 
Slope (m) 18117 
Intercept (c) 26866 
LOD  2.82µg/ml 
LOQ  8.54µg/ml 
 
Table 3: Analysis of tablet formulation 
 
 
 
Formulation Concentration 
(ppm) 
Percentage of drug 
estimated 
Statistical analysis 
Tab. 
Telma 
60 58.42 Mean-58.94  
%RSD-0.89 60 59.47 
60 58.94 
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Table 4: Precision data 
Days Fortified 
amount 
(ppm) 
Amount found 
(ppm) 
% RSD 
Intraday 
(n = 3)  
40 39.39 1.48 
60 58.94 0.86 
100 101.13 1.36 
Interday  
(n = 3) 
40 37.79 1.29 
60 58.57 0.98 
100 100.86 1.46 
Repeatability  (n = 6) 60 57.99 0.51 
 
Table 5: Results of robustness study 
Chromatographic conditions Normal  Variation Drug amount %RSD 
Change in composition 
Mobile phase 
(methanol : acetonitrile) 
90 : 10 88 : 12 54.44 0.86 
 92 : 08 49.72 0.54 
Flow rate(ml/min) 1.0 0.9 55.31 0.53 
  1.1 60.93 0.76 
 
Table 6: Results of % recovery in tablet formulation 
Concentration % of 
spiked level 
Amount of drug added (ppm) Amount of pure 
drug found 
(ppm) 
% 
Recovery 
Statistical 
analysis of % 
recovery 
  Pure drug Formulation  
80%     sample 1 18 30 48.50 101.68 Mean-103.18  
%RSD-1.53 80%     sample 2 18 30 49.45 104.83 
80%     sample 3 18 30 48.91 103.03 
100%   sample 1 30 30 60.28 100.96 Mean- 100.87 
%RSD-1.82 100%   sample 2 30 30 59.69 98.99 
100%   sample 3 30 30 60.80 102.67 
120%   sample 1 42 30 68.26 87.55 Mean- 87.3 
%RSD-1.87 120%   sample 2 42 30 67.65 85.55 
120%   sample 3 42 30 68.42 88.80 
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4. Conclusion  
A  validated  RP-HPLC  analytical  method  
has  been  developed  for  the  determination  of 
telmisartan in  bulk  and  dosage  form.  The  
proposed  method  was  simple,  accurate,  precise,  
specific and suitable  to  use  for  the  routine  
analysis  of  telmisartan in  either  bulk  API  powder 
or in pharmaceutical  dosage  forms. The  simplicity  
of  the  method  allows  for  application  in 
laboratories  that  lack  sophisticated  analytical  
instruments  such  as  LC–MS  and  GC–MS. These  
methods  are  complicated,  costly  and  time  
consuming  rather  than  a  simple  HPLC-UV 
method.  
 
References 
1. Sethi PD. Quantitative analysis of drugs in 
pharmaceutical formulations, Third edition, CBS 
Publishers 1997; 5-60. 
2. ICH Q2B, Harmonized Triplicate Guideline, 
Validation of analytical Procedure Methodology. 
IFPMA, Proceeding of the International 
Conference on Harmonization. Geneva, March 
1996. 
3. ICH, Q2A, Harmonized Tripartite Guideline, 
Validation of analytical Procedure Methodology. 
IFPMA, Proceedings of the International 
Conference on Harmonization. Geneva. March 
1994. 
4. Telmisartan, Information from Drugs. com., 
http://www.drugs.com Monograph/ Telmisartan. 
html (Accessed on June 2012) 
5. Gowri SD, Sujana K. „Stability indicating RP-
HPLC method for determination of telmisartan in 
pure and pharmaceutical formulation‟, 
International Journal of Pharmacy and 
Pharmaceutical Sciences 2011; 231-240. 
6. Kale DM. „Stability indicating RP-HPLC method 
for estimation of telmisartan related substances in 
tablet formulation‟, International Journal of 
Research Pharm. Sciences.2010; 1: 100-109. 
7. Mahdik KR, Agrawal H. „Stability indicating RP-
HPLC method for analysis of telmisartan in the 
bulk drug and formulation‟, Acta 
Chromatographica.  
 
 
 
 
 
 
 
 
 
 
 
 
 
